跳至主要内容
临床试验/NCT05152589
NCT05152589Unknown不适用

Newborn Hearing Loss

Ankara City Hospital Bilkent1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Hearing Loss

研究概览

简要总结

This study aims to investigate the presence and characteristics of maternal diabetes as a risk factor in newborns with hearing loss.

Hearing loss is one of the most common congenital anomalies among newborns. The newborn hearing screening program is important for early diagnosis in newborns with hearing loss.Gestational diabetes, on the other hand, is a metabolic disease that occurs during pregnancy and can cause complications as in other diabetes mellitus patients.

Despite our knowledge of major complications, the effect of the hyperglycemic intrauterine environment on hearing outcomes has not been adequately studied. The inner ear does not store energy, so it has a particularly high sensitivity to altered blood sugar and insulin. Altered inner ear metabolism leads to auditory and balance disorders.

There is no study in the literature comparing uncomplicated gestational diabetes and pregestational diabetes as a prenatal complication that poses a risk of hearing loss.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • POSTNATAL AGE BETWEEN 0-28 DAYS
  • BIRTH WEIGHT ≥2000GR
  • TO HAVE TESTED ON THE NEWBORN HEARING SCREENING UNIT AT ANKARA CITY HOSPITAL

排除标准

  • CRANIOFACIAL ANOMALIES
  • INTRAUTERINE INFECTIONS
  • BIRTH WEIGHT <2000 GR

结局指标

主要结局

Hearing Loss

时间窗: 6 months

Hearing test results in babies with no diabetes, pregestational diabetes, and gestational diabetes

次要结局

  • diabetic mother(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验